Decreto 824/2010 ((full)) — Real

The , of June 25, is the foundational piece of Spanish legislation regulating pharmaceutical laboratories, manufacturers of active substances, and the foreign trade of medicines. By integrating multiple European directives into a single framework, it ensures that all drugs—whether for human use, veterinary use, or research—meet strict safety and quality standards. Key Objectives of the Decree

Manufacturers of active pharmaceutical ingredients (APIs) must also be registered, and laboratories must verify the quality and origin of these substances. real decreto 824/2010

Article 38 (as referenced in related safety literature) requires technical directors to ensure staff receive continuous training and that safety protocols for handling hazardous drugs are implemented. The , of June 25, is the foundational

The decree was enacted to address the unregulated production and release of aquatic species, which posed risks of introducing diseases and altering the genetic makeup of wild populations. Article 38 (as referenced in related safety literature)

The regulation requires laboratories to follow EU-harmonized Good Manufacturing Practices.

Specific rules apply to the import/export of medicines and the manufacturing of "Investigational Medicinal Products" (IMPs) used in clinical trials.

This is the core of the decree. It enforces strict sanitary controls to prevent the spread of pathogens.